Sarcopenia Risk Calculator

SARC-F's developers validated 4 out of a possible 10 points as the threshold that best balances sensitivity and specificity for identifying people who are likely to have sarcopenia when measured objectively, rather than requiring a near-maximal score before flagging concern. Using a lower, validated cutoff is intentional: SARC-F is meant to be a quick screening tool that casts a wide enough net to catch probable cases for follow-up testing, not a diagnostic threshold requiring severe self-reported impairment across every item.

Average grip strength differs substantially between sexes even in healthy adults due to differences in baseline muscle mass, so the EWGSOP2 consensus set sex-specific cutoffs -- below 27 kg for men and below 16 kg for women -- rather than a single value that would systematically misclassify one sex. Using a unisex cutoff would either flag too many healthy women as weak or miss genuinely weak men, since a "low" grip strength for a man is well within the normal range for many women.

Probable sarcopenia is flagged by low muscle strength alone -- either a positive SARC-F screen or low grip strength -- and is generally enough to justify starting intervention like resistance exercise without waiting for further testing. Confirmed sarcopenia requires that low strength finding alongside objective evidence of reduced muscle quantity or quality specifically (approximated here by low calf circumference), not reduced physical performance -- EWGSOP2 treats gait speed as a separate physical- performance criterion that instead escalates confirmed sarcopenia to severe once both low strength and low muscle quantity/quality are already present, reflecting the EWGSOP2 principle that strength loss is the practical trigger for action while muscle-quantity evidence confirms the diagnosis and gait speed marks its severity.

Grip strength and gait speed capture related but distinct aspects of neuromuscular function -- grip strength reflects a specific, easily standardized measure of maximal force generation, while gait speed integrates strength, balance, coordination, and cardiovascular capacity into a whole-body functional performance measure. A gait speed below 0.8 m/s is independently associated with disability and mortality risk in older adults, which is why EWGSOP2 treats it as a marker of physical performance and potential sarcopenia severity distinct from strength alone.